![Viktor Roschke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Viktor Roschke
Chief Tech/Sci/R&D Officer at
D&D PHARMATECH INC.
Net worth: 30 M $ as of 2026-05-30
Profile
Viktor Roschke is the founder of Neuraly, Inc. since 2016, holding the title of Director & Chief Scientific Officer.
Current jobs include Secretary & Director at Theraly Fibrosis, Inc. and Chief Scientific Officer at D&D Pharmatech Co., Ltd. Former jobs include Executive Director-Cell Biology at Human Genome Sciences, Inc. from 2005, VP-Biopharmaceutical Research & Assay Development at Zyngenia, Inc., and Chief Operating Officer at Teva Biopharmaceuticals USA, Inc. Education includes a doctorate from Novosibirsk State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-06-03 | 482,036 ( 1.1% ) | 30 M $ | 2026-05-30 |
Viktor Roschke active positions
| Companies | Position | Start |
|---|---|---|
| D&D PHARMATECH INC. | Chief Tech/Sci/R&D Officer | - |
Theraly Fibrosis, Inc.
 Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Director/Board Member | - |
Neuraly, Inc.
 Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Founder | 2015-12-31 |
Former positions of Viktor Roschke
| Companies | Position | End |
|---|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | 2004-12-31 |
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Develops and commercializes biological products | Chief Operating Officer | - |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Chief Tech/Sci/R&D Officer | - |
Training of Viktor Roschke
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
40
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Retail Trade |
Novosibirsk State University
 Novosibirsk State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Develops and commercializes biological products | Health Technology |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Commercial Services |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
D&D Pharma Tech Co., Ltd.
 D&D Pharma Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Viktor Roschke
